Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. Hamaguchi, N. Yamamoto, Y. Akeda, P. Santanirand, A. Kerdsin, M. Seki, W. Phang, K. Malathum, K. Oishi, K. Tomono (Osaka, Tokyo, Japan; Bangkok, Thailand). Direct LAMP assay from clinical sample for carbapenem resistant A. baumannii. Eur Respir J 2014; 44: Suppl. 58, 2473

Member's Comments

No comment yet.

Related content which might interest you: Multidrug resistant acinetobacter baumannii in ventilator associated pneumonia: Prevalence and predictors of mortality Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014 Rapid quantification of bacteria associated to ventilator associated pneumonia in endotracheal aspirate specimens Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Ventilator-associated pneumonia due to colistin susceptible-only microorganisms Source: Eur Respir J 2007; 30: 307-313 Year: 2007 Community-acquired pneumonia due to multidrug and non-multidrug resistant pseudomonas aeruginosa Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Methicillin-resistant staphylococcus aureus: The most prevalent cause of ventilator associated pneumonia in Tehran hospitals Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Ventilator-associated pneumonia (VAP) pathogenic microorganisms eradication and persistence during antimicrobial therapy Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013 Potential treatment for nosocomial respiratory strains of extreme drug resistant acinetobacter baumanii Source: Eur Respir J 2007; 30: Suppl. 51, 410s Year: 2007 Aetiopathogenesis of VAP revisited Source: Eur Respir Mon 2011; 53: 1-10 Year: 2011 VAP: approach to therapy Source: Eur Respir Mon 2011; 53: 36-47 Year: 2011 Monitoring of antimicrobial resistance respiratory strains of streptococcus pneumoniae Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia Source: Eur Respir J 2007; 29: 548-560 Year: 2007 Frequency of multidrug resistant pathogens in healthcare associated pneumonia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Multidrug resistant acinetobacter baumanii pneumonia: Mortality analysis and comparison of intravenous versus aerosolized therapy Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Implications of identifying the pathogen in ventilator-associated pneumonia (VAP) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Pseudomonas, enterobacteriaceae ESBL positive and staphylococcus MRSA: When to suspect them in CAP? Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Prognosis of Acinetobacter baumannii bacteraemia in a respiratory ICU: 10 years‘ experience Source: Eur Respir J 2005; 26: Suppl. 49, 222s Year: 2005 Antibiotic sensitivity of pseudomonas aeroginosa isolates of respiratory secretions taken from ICU patients of the NRITLD Source: Eur Respir J 2004; 24: Suppl. 48, 641s Year: 2004 Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014 Factors associated with mortality in ventilator associated pneumonia of multidrug resistant acinetobacter baumannii Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013